Day's Low
Day's High
52 Week's Low
52 Week's High
Returns % | |
1 Month Return | -4.92 % |
3 Month Return | -34.42 % |
1 Year Return | -6.17 % |
Market Stats | |
Previous Close | ₹192.30 |
Open | ₹192.40 |
Volume | 1.08L |
Upper Circuit | - |
Lower Circuit | - |
Market Cap | ₹236.62Cr |
P/E Ratio | 0 |
PEG Ratio | 0 |
Market Cap | ₹236.62 Cr |
P/B Ratio | 3.1 |
EPS | 0 |
Dividend Yield | 0 |
Sector | Pharmaceuticals |
ROE | 18.49 |
Company | Analyst View | Market Cap | 5 Year CAGR | Debt to Asset Ratio | Net Profit | Yearly Revenue |
---|---|---|---|---|---|---|
NA | ₹236.62 Cr | 199.4% | 0.50 | NA | NA | |
NA | ₹5,044.92 Cr | 65.41% | 0.52 | -₹71 Cr | ₹1,704 Cr | |
NA | ₹2,549.73 Cr | 83.05% | 0.56 | -₹15 Cr | ₹180 Cr | |
NA | ₹712.10 Cr | 199.49% | 0.91 | ₹55 Cr | ₹575 Cr | |
BUY | ₹7,153.68 Cr | 1547.17% | 0.55 | ₹95 Cr | ₹819 Cr |
Organisation | Par Drugs & Chemicals Ltd |
Headquarters | |
Industry | Pharmaceuticals |
E-voting on shares | Click here to vote |
Key events for Par Drugs & Chemicals Ltd
Par Drugs & Chemicals Ltd Shows Strong Growth Potential - 05 Apr, 2024
Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.
Price Rise
In the last 7 days, PAR stock has moved up by 2.6%
Retail Holding Up
Retail Investor have increased holdings from 25.47% to 26.54% in Sep 2024 quarter
Against Peers
In the last 3 years, Torrent Pharmaceuticals Ltd has given 148.2% return, outperforming this stock by 134.7%
Against Peers
In the last 1 year, Divis Laboratories Ltd has given 51.5% return, outperforming this stock by 53.8%
Promoter Holding Down
Promoters have decreased holdings from 74.21% to 73.37% in Sep 2024 quarter
FII Holding Down
Foreign Institutions have decreased holdings from 0.32% to 0.09% in Sep 2024 quarter
Investors | Holdings % | FY Quarter | 3M change |
---|---|---|---|
Promoter Holdings | 73.37% | ||
Foreign Institutions | 0.09% | ||
Mutual Funds | 0% | 0.00 | |
Retail Investors | 26.54% | 4.22 | |
Others | 0% | 0.00 |
Par Drugs & Chemicals Ltd’s net profit jumped 75.87% since last year same period to ₹8.60Cr in the Q2 2024-2025. On a quarterly growth basis, Par Drugs & Chemicals Ltd has generated 239.92% jump in its net profits since last 3-months.
Read More about Earnings ResultsIn the quarter ending September 2021, Par Drugs & Chemicals Ltd has declared dividend of ₹1.25 - translating a dividend yield of 0.65%.
Read More about DividendsBearish
Neutral
Bullish
Par Drugs & Chemicals Ltd is currently in a Bearish trading position according to technical analysis indicators.
Par Drugs & Chemicals Ltd share price today stands at ₹192.4, Open: ₹192.4, Previous Close: ₹192.3, High: ₹193, Low: ₹192.35, 52 Week High: ₹348.45, 52 Week Low: ₹180.5.
Par Drugs & Chemicals Ltd is listed on NSE
Par Drugs & Chemicals Ltd is not listed on BSE
Today's traded volume of Par Drugs & Chemicals Ltd(PAR) is 1.08L.
Today's market capitalisation of Par Drugs & Chemicals Ltd(PAR) is ₹236.62Cr.
Par Drugs & Chemicals Ltd (PAR) share price is ₹192.4. It is down -44.78% from its 52 Week High price of ₹348.45
Par Drugs & Chemicals Ltd (PAR) share price is ₹192.4. It is up 6.59% from its 52 Week Low price of ₹180.5